Indian insurance companies are asking the regulator for permission to aggregate equity derivative exposure across multiple funds. While the regulator allowed these tools for hedging in February 2025, adoption has been minimal due to strict fund-level constraints. This change could improve risk management efficiency, though the regulator will likely prioritize strict safeguards against excessive leverage.
Indian life and general insurance companies are currently in discussions with the Insurance Regulatory and Development Authority of India (IRDAI) to seek greater flexibility in how they use equity derivatives for portfolio hedging. The industry's primary request is to transition from current fund-level restrictions to a system that allows for the aggregation of derivative exposure across multiple funds. This, they argue, would provide the operational efficiency needed to manage risk across large, multi-product equity portfolios.
The regulatory framework currently in place dates back to February 2025, when the IRDAI first permitted insurers to use equity derivatives. The objective was to provide insurers with a mechanism to hedge their existing equity positions against market volatility, thereby protecting the value of long-term investments. However, adoption of these instruments has remained extremely low. Industry data suggests that only one life insurer has utilized equity derivatives to date, with activity restricted to a very small number of transactions.
For insurers, the current fund-by-fund limitation is seen as a practical hurdle. Because insurance companies manage capital across diverse products and funds, applying derivative limits separately to each pool restricts their ability to hedge the broader market risk shared across their entire equity portfolio. The industry believes that allowing the aggregation of these limits would match better with long-term portfolio management goals without turning insurers into speculative traders.
From an investor perspective, this development is worth monitoring regarding the major listed insurance companies in India, such as HDFC Life, SBI Life, and ICICI Prudential Life. While there is no immediate financial impact from this news—as no rule change has been announced and current derivative usage is negligible—broader hedging flexibility could eventually improve these companies' ability to protect their balance sheets during periods of sharp market volatility.
The regulator remains cautious in its approach, balancing the industry's need for flexibility against the potential risks associated with derivatives. These instruments, while useful for hedging, introduce complexities such as counterparty risk, liquidity issues, and the need for rigorous internal monitoring to prevent the build-up of excessive leverage or speculative positions. Any eventual relaxation of the rules will likely be accompanied by strict disclosure requirements and operational safeguards to ensure policyholder protection.
The next important update for investors will be whether the IRDAI issues new guidelines or a circular responding to these industry requests. Until such a change is announced, current restrictions remain in effect, and the use of derivatives by insurers is likely to stay limited.